Role of Endogenous Endothelin in Chronic Heart Failure: Effect of Long-term Treatment With an Endothelin Antagonist on Survival, Hemodynamics, and Cardiac Remodeling
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background Plasma levels of the vasoconstrictor peptide endothelin (ET) are increased in chronic heart failure (CHF), and ET levels are a major predictor of mortality in this disease. Thus, ET may play a deleterious role in CHF. The purpose of this study was to assess the effects of chronic treatment with the ET receptor antagonist bosentan in a rat model of CHF. Methods and Results Rats were subjected to coronary artery ligation and were treated for 2 or 9 months with placebo or bosentan (30 or 100 mg · kg−1· d−1). Bosentan 100 mg · kg−1 markedly increased survival (after 9 months: untreated, 47%; bosentan, 65%;P<.01). Throughout the 9-month treatment period, bosentan significantly reduced arterial pressure and heart rate. After 2 or 9 months of treatment, the ET antagonist reduced central venous pressure and left ventricular (LV) end-diastolic pressure as well as plasma catecholamines, urinary cGMP, and LV ventricular collagen density. Bosentan also reduced LV dilatation (evidenced at 2 months by a shift in the pressure/volume relationship ex vivo). Echocardiographic studies performed after 2 months showed that the ET antagonist reduced hypertrophy and increased contractility of the noninfarcted LV wall. The lower dose of bosentan (30 mg · kg−1), which had no major hemodynamic or structural effects, also had no effect on survival. Conclusions Long-term treatment with an ET antagonist markedly increases survival in this rat model of CHF. This increase in survival is associated with decreases in both preload and afterload and an increase in cardiac output as well as decreased LV hypertrophy, LV dilatation, and cardiac fibrosis. Thus, chronic treatment with ET antagonists such as bosentan might be beneficial in human CHF and might increase long-term survival in this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,897
Myocardial infarct size and ventricular function in rats.
Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C., Fletcher, P. J., Spadaro, J., Kloner, R. A., & Braunwald, E. (1979) · Circulation Research · doi:10.1161/01.res.44.4.503 · Cited by 1,281
Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., & Finn, P. (1985) · Circulation · doi:10.1161/01.cir.72.2.406 · Cited by 718
Clozel, M., Breu, V, Gray, G. A., Kalina, B., Löffler, B. M., Burri, K., Cassal, J. M., Hirth, G., Müller, M., & Neidhart, W. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22357-6 · Cited by 661
Clearance of Circulating Endothelin-1 by ETB Receptors in Rats
Fukuroda, T., Fujikawa, T., Ozaki, S., Ishikawa, K., Yano, M., & Nishikibe, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1395 · Cited by 625
Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
Sakai, S., Miyauchi, T., Kobayashi, M., Yamaguchi, I., Goto, K., & Sugishita, Y. (1996) · Nature · doi:10.1038/384353a0 · Cited by 622
Endothelin in human congestive heart failure.
Wei, C. M., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Brandt, R. R., Wright, S., Heublein, D. M., Kao, P. C., Edwards, W. D., & Burnett, J. C. (1994) · Circulation · doi:10.1161/01.cir.89.4.1580 · Cited by 586
Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
Kiowski, W., Kim, J., Oechslin, E., Sütsch, G., Hunziker, P., Müller, P., Bertel, O., Schmitt, R., & Jones, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91504-4 · Cited by 571
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium.
Weber, K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M., & Bashey, R. I. (1988) · Circulation Research · doi:10.1161/01.res.62.4.757 · Cited by 556
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo, B., Oemar, B. S., Siebenmann, R., von Segesser, L., & Lüscher, T. F. (1994) · Circulation · doi:10.1161/01.cir.89.3.1203 · Cited by 517
Plasma endothelin in chronic heart failure.
McMurray, J. J., Ray, S. G., Abdullah, I., Dargie, H. J., & Morton, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.4.1374 · Cited by 486
Litwin, S. E., Katz, S. E., Morgan, J. P., & Douglas, P. S. (1994) · Circulation · doi:10.1161/01.cir.89.1.345 · Cited by 421
Omland, T., Lie, R. T., Aakvaag, A., Aarsland, T., & Dickstein, K. (1994) · Circulation · doi:10.1161/01.cir.89.4.1573 · Cited by 403
The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo
Clozel, M., Gray, G. A., Breu, V., Löffler, B.-M., & Osterwalder, R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90826-7 · Cited by 403
Fletcher, P. J., Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1981) · Circulation Research · doi:10.1161/01.res.49.3.618 · Cited by 362
Lüscher, T. F., Yang, Z., Tschudi, M., von Segesser, L., Stulz, P., Boulanger, C., Siebenmann, R., Turina, M., & Bühler, F. R. (1990) · Circulation Research · doi:10.1161/01.res.66.4.1088 · Cited by 292
Effects of endothelins on collagen turnover in cardiac fibroblasts
Guarda, E., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Sakai, S., Miyauchi, T., Sakurai, T., Kasuya, Y., Ihara, M., Yamaguchi, I., Goto, K., & Sugishita, Y. (1996) · Circulation · doi:10.1161/01.cir.93.6.1214 · Cited by 286
Increased endothelin in experimental heart failure.
Margulies, K. B., Hildebrand, F. L., Lerman, A., Perrella, M. A., & Burnett, J. C. (1990) · Circulation · doi:10.1161/01.cir.82.6.2226 · Cited by 284
Elevated endothelin-1 in heart failure and loss of normal response to postural change.
Stewart, D. J., Cernacek, P., Costello, K. B., & Rouleau, J. L. (1992) · Circulation · doi:10.1161/01.cir.85.2.510 · Cited by 245
Love, M. P., Haynes, W. G., Gray, G. A., Webb, D. J., & McMurray, J. J. V. (1996) · Circulation · doi:10.1161/01.cir.94.9.2131 · Cited by 182
Teerlink, J. R., Löffler, B. M., Hess, P., et al. (1994) · Circulation · doi:10.1161/01.cir.90.5.2510 · Cited by 163
Lerman, A., Kubo, S. H., Tschumperlin, L. K., & Burnett, J. C. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90183-n · Cited by 158
Cannan, C. R., Burnett, J. C. J., & Lerman, A. (1996) · Circulation · doi:10.1161/01.cir.93.4.646 · Cited by 106
Mulder, P. G. H., Richard, V. J., Compagnon, P., Henry, J., Lallemand, F., Clozel, J., Koen, R., Macé, B., & Thuillez, C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00491-3 · Cited by 72
Self-citationEarly Versus Delayed Angiotensin-Converting Enzyme Inhibition in Experimental Chronic Heart Failure
Mulder, P. G. H., Devaux, B., Richard, V. J., Henry, J., Mc, W., Thibout, E., Macé, B., & Thuillez, C. (1997) · Circulation · doi:10.1161/01.cir.95.5.1314 · Cited by 65
Self-citationNegative Chronotropic Effect of Endothelin 1 Mediated Through ETAReceptors in Guinea Pig Atria
Ono, K., Eto, K., Sakamoto, A., Masaki, T., Shibata, K., Sada, T., Hashimoto, K., & Tsujimoto, G. (1995) · Circulation Research · doi:10.1161/01.res.76.2.284 · Cited by 41
Is There a Role for Endothelin in the Natural History of Heart Failure?
Cohn, J. N. (1996) · Circulation · doi:10.1161/01.cir.94.4.604 · Cited by 27
Cited by
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Haddad, F., Hunt, S. A., Rosenthal, D. N., & Murphy, D. J. (2008) · Circulation · doi:10.1161/circulationaha.107.653576 · Cited by 1,523
Haddad, F., Doyle, R., Murphy, D. J., & Hunt, S. A. (2008) · Circulation · doi:10.1161/circulationaha.107.653584 · Cited by 1,304
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
“In experimental animal models of hypertensive heart disease and of reparative myocardial fibrosis, ET-1 inhibition reduced fibrotic remodelling.(280,281)”
Background
Metadata
- Authors
- Mulder, P., Richard, V., Derumeaux, G., Hogie, M., Henry, J. P., Lallemand, F., Compagnon, P., Macé, B., Comoy, E., Letac, B., & Thuillez, C.
- Venue
- Circulation
- Published
- 1997-09-16
- Volume
- 96
- Issue
- 6
- Pages
- 1976-1982
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2050153745
- Cited by
- 360
- References
- 30
- FWCI
- 18.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.